Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LGVN
#538
Longeveron Inc. Common Stock
0.973
5
USD
+20.33%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+20.33%
Monthly Change
+70.40%
6 month change
+70.40%
Year Change
+70.40%
Previous Close
0.809
0
Open
0.973
5
Bid
0.973
5
Ask
0.976
5
Low
0.973
5
High
0.973
5
Volume
14
Markets
US Stock Market
Healthcare
LGVN
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2021
2022
2023
2024
TTM
Cash from operating activities
9.64 M
13.97 M
19 M
13.87 M
16.72 M
Cash from investing activities
10.7 M
677 K
8.19 M
640 K
654 K
Cash from financing activities
45.17 M
509 K
5.26 M
28.79 M
3.84 M
Free cash flow
8.33 M
13.11 M
18.31 M
12.88 M
16.07 M
News
Longeveron closes $15 million financing, extends runway to 4Q26
Longeveron secures $15M financing, eyes $15M more on trial results
Longeveron publishes phase 2b stem cell trial results in journal
Longeveron appoints Stephen Willard as new CEO ahead of pivotal trial results
Longeveron receives Japanese patent for stem cell potency assay methods
Longeveron prepares for pivotal HLHS therapy data with FDA meeting
Longeveron receives patent for stem cell therapy targeting female sexual dysfunction
Longeveron executives to speak at CVCT Forum on cell therapy trials
Longeveron receives Canadian patent for stem cell therapy
Longeveron’s stem cell therapy shows reduced neuroinflammation in AD trial
Longeveron to present Alzheimer’s treatment data at CTAD 2025
Longeveron secures patent for stem cell therapy targeting aging frailty